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T
he recent increase in the worldwide prevalence
of obesity has understandably focused attention
on the environmental determinants of this epi-
demic. Whereas identifying the relative contribu-
tions of the factors underlying this recent trend is critical,
a comprehensive understanding of the causes of obesity
will need to explain why, even in high-risk populations,
many people remain lean. Contemporary studies indicate
that the heritability of adiposity remains high, even in the
face of a strongly obesogenic environment. Whereas the
role of inheritance has long been appreciated, only re-
cently have we begun to develop a genuine understanding
of the critical role of speciﬁc molecules in sensing the
state of nutrient storage and regulating food intake and
energy expenditure. Notably, a number of single gene
disorders resulting in human obesity have been uncovered
and, strikingly, all of these defects impair the central
control of food intake. Early indications are that common
genetic variants inﬂuencing adiposity on a population level
affect the same processes. While the rising prevalence of
obesity is related to increasing ease of access to high-
energy palatable food combined with diminishing require-
ment for physical activity, differences in inter-individual
susceptibility to obesity are likely to be related to inherited
variation in the efﬁciency of central control mechanisms
inﬂuencing eating behavior. Such a construct understand-
ably courts unpopularity, since it can appear to diminish
the importance of human free will and is perceived by
some as representing a counsel of despair and an “excuse”
for otherwise controllable behavior. We argue that a view
of obesity that emphasizes the profound biological basis
for inter-individual differences in responding to the chal-
lenges of achieving a healthy control of nutrient intake
should result in a more enlightened attitude toward people
with obesity with a consequent reduction in their experi-
ence of social and economic discrimination. In the longer
term, this may also lead to more efﬁcacious individually
targeted approaches to the treatment and prevention of
obesity.
The obesity epidemic. Obesity is a major risk factor for
premature mortality from cardiovascular and metabolic
diseases and certain cancers and for greatly increased
morbidity from osteoarticular, gastrointestinal, reproduc-
tive, and other disorders (1). It carries an enormous
burden of health care costs (2). Therefore, evidence that
its prevalence has been increasing and continues to in-
crease in most developed and developing countries (3,4) is
a cause for major concern.
Whereas much of the epidemiological data suggest that
even moderate degrees of overweight are associated with
adverse effects on morbidity and mortality at the popula-
tion level, there is some controversy about the overall
impacts on mortality of moderate weight gain (5). More
severe degrees of obesity bring a considerable burden of ill
health and social and economic discrimination (6) and
have adverse impacts on well-being and psychological and
social functioning (7). It is worth noting that the relative
importance of particular etiological factors for obesity is
likely to be different when considering mild overweight
versus morbid obesity and that interventions that may
make a clinically signiﬁcant impact on the overweight may
have negligible beneﬁcial effects in a morbidly obese
person. Given what we already know about the etiological
heterogeneity of obesity, it is important to emphasize that
different forms of intervention may be needed for people
with different subtypes of this condition.
The contributions of the various environmental factors
that are driving increasing obesity rates are hard to
quantitate precisely and are likely to differ in degree
between populations. They are certainly likely to include
factorsthatmakethepurchaseandconsumptionofenergy-
dense food easier and the expenditure of physical activity
as part of daily life more difﬁcult. However, it is undoubt-
edly true that, except for some population isolates, even in
geographical areas where obesity rates are highest, a
substantial proportion of the population has remained lean
(5). In our opinion, there are really only two basic expla-
nations (and they are not necessarily mutually exclusive)
for how these people have avoided the “toxic” effects of
environment. The one that intuitively appeals to the mass
media (and to many lean people) is that this group is
largely made up of individuals who have made conscious
choices about diet and exercise and have actively fought
off the “toxic environment.” An alternative explanation,
much less frequently cited in public debate, is that this
group of subjects are somehow biologically different and
achieve their leanness largely through unconscious mech-
anisms. In this review, we would like to explore this
hypothesis in more detail. We will argue that the heritable
(and therefore biological) inﬂuences on human adiposity
are strong and remain so in the midst of the epidemic. We
will also argue that while some of that hereditary inﬂuence
is likely to affect processes such as energy expenditure
and nutrient partitioning, what we have discovered thus
far about the genes inﬂuencing human obesity strongly
suggests that heritable differences in neurobehavioral
traits inﬂuencing habitual eating behavior such as hunger,
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more important.
Hereditary inﬂuences on adiposity are profound and
continuing. The heritability of human traits such as
adiposity is most robustly assessed by studies of monozy-
gotic versus dizygotic twins (8–10). In the case of traits
such as BMI, which are readily assessed in large numbers,
we have access to the extraordinarily powerful data that
can come from the study of adult pairs of identical twins
that have been adopted as infants and raised separately by
different biologically unrelated families (11,12). There are
numerous classical twin studies in obesity, and the aver-
age heritability (i.e., proportion of inter-individual differ-
ence in a trait explicable by genetic variability) reported
consistently in these studies on the order of 40–75%
(8,11,12). The classical “adopted-separated twin” study of
Stunkard et al. (12) showed no signiﬁcant correlation
between adult BMI of a twin with the members of a family
into which they had been adopted, while the correlation
coefﬁcient of BMI of one twin with their co-twin (who, in
most cases, they had not seen since the ﬁrst months of life)
was 0.7. These remarkable data have never been seriously
challenged, and their implications are profound.
Critics of the use of such twin-based methodologies to
quantitate the inﬂuence of heredity on various traits point
to the importance of the prenatal environment and the
likely differences in placentation and intrauterine nutrition
between twins and singletons, on the one hand, and
between monozygotic and dizygotic twins on the other.
This has led some to dismiss the utility of such measures
of heritability altogether (13). While accepting the likely
importance of “prenatal programming” (14), it seems to us
that this view is oversimplistic and risks throwing the baby
out with the bathwater. In general, where twin and family
studies have demonstrated high heritability of a readily
measurable trait (e.g., height), appropriately powerful
molecular genetic studies are now revealing the identity of
these genetic variants and providing conclusive proof that
these genetic effects are not “mythical” (15). In the case of
adult BMI, in fact, there is little evidence that birth weight
(a widely accepted, if crude, measure of intra-uterine
nutrition) has any consistently signiﬁcant association. In
brief, if twin (and particularly adopted-separated twin)
studies show consistent and strong evidence for a high
heritability, then it is very likely that inherited variation in
genomic DNA sequence will have a major inﬂuence on a
trait. There is little serious doubt that the single most
powerful determinant of inter-individual differences in
adiposity is heredity (16).
It is true that many of the classical twin studies of
obesity occurred before the recent obesity epidemic.
Might it be the case that the importance of hereditary
factors has diminished in recent years as the environmen-
tal effects have become more pronounced? Notably,
Wardle et al. (17) have recently reported a study of 5,092 8-
to 11-year-old twins living in London, U.K., and measured
in 2005. Strikingly, the estimate of heritability of both BMI
and waist circumference was 77%. Thus, in the midst of the
obesity epidemic, the evidence that hereditary factors are
important remains unassailable. In the understandable
rush to ﬁnd potentially reversible environmental causes
for the epidemic of obesity, it is not surprising that this
fact is not infrequently downplayed. For example, Reilly et
al. (18) recently reported the most comprehensive pro-
spective studies of risk factors determining obesity at age
7 years. Some environmental factors such as maternal
smoking and hours of television viewed daily showed a
relationship with BMI with odds ratios reaching 1.5–1.8 at
the highest levels of exposure. However, in this study, if
both parents were obese, the odds ratio of obesity in the
child was 10.4, and if adiposity rebound occurred in a child
before 43 months, the odds ratio was 15. Clearly, there are
potential unmeasured environmental explanations for
both these striking associations, but it is equally (if not
more) plausible that biological and inherited factors pre-
dominantly underlie both these associations. In the exten-
sive debate that followed the publication of that article
(19), it is remarkable that little or no attention was paid to
the factors that had been clearly demonstrated to have by
far the highest impact. We shall return later to some
possible reasons why broad acceptance of the strength of
the heritable and biological predisposition to obesity is
difﬁcult to secure.
Energy balance is a physiologically controlled
process. If genetic variation inﬂuences body fat stores, then
it must do so through biological and not “metaphysical”
processes. A body of work stretching over nearly 70 years
has clearly demonstrated that energy balance in mammals is
a homeostatically regulated process involving a dialogue
between the sites of long-term energy stores, i.e., adipose
tissue, and the brain, the organ that coordinates food
intake and related behaviors and is the central control of
energy expenditure (20–23). Over the past 15 years or so,
molecular ﬂesh has been put on the bones of these
concepts by the work largely emanating from the study of
inherited obesity in rodents, which has ﬁrmly established
the leptin-melanocortin signaling link as critical to the
normal control of energy homeostasis (24–27). The con-
trol of energy stores is clearly not subject to the same tight
constraints as, say, that of plasma osmolality (another
physiological parameter governed by hypothalamic pro-
cesses involving both a sensation leading to a behavior
[thirst drinking] and a hormonal output [i.e., vasopressin]);
absolute amounts of fat stored therefore vary between
individuals and across a lifetime. But there does tend to be
a degree of intra-individual stability, with homeostatic
processes kicking in to restore weight to its original levels
after periods of weight loss and, in some individuals at
least, the tendency of weight to return to its previous level
after a period of experimental overfeeding (28–30).
Severe defects in single genes involved in these
processes cause human obesity largely through im-
pact on appetite. Over the past decade or so, mutations
in speciﬁc genes have been found to cause certain mono-
genic forms of human obesity (31). Certain pleiotropic
genetic disorders have long been identiﬁed as being asso-
ciated with obesity as well as features such as mental
retardations and various dysmorphisms. Some, such as
Prader-Willi syndrome, are well known to be associated
with extreme hyperphagia, but the complex nature of the
imprinting defect in Prader-Willi syndrome makes it difﬁ-
cult to mechanistically link the genetic defect with the
pathophysiology (32). Numerous subtypes of Bardet-Biedl
syndrome are also associated with obesity as well as
retinitis pigmentosa, renal abnormalities, mental retarda-
tion, and other features, and, intriguingly, many of these
effects appear to affect proteins localized to the basal
body, a key element of the monocilium thought to be
important for intercellular sensing (33). However, it is the
identiﬁcation of genetic defects in obese children without
the typical features of the classical syndromes that has
provided the best evidence to date that the physiological
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operative in humans. Homozygous or compound heterozy-
gous loss of function mutations in ﬁve different genes
operating within the canonical leptin-melanocortin signal-
ing pathway clearly and replicably result in human obesity
(34–39). Individual patients with haplo-insufﬁciency for
Sim 1 (a transcription factor necessary for normal hypo-
thalamic development) (40) and for brain-derived neuro-
trophic factor (41), as well as a heterozygous loss-of-
function missense mutation in its receptor Trk B (42), all
develop severe obesity in association with other develop-
mental features.
From this body of work, we now know that 1) humans
can become obese as a result of simple genetic defects, 2)
one of those defects (leptin deﬁciency) is effectively
treated by hormone replacement (43), and 3) MC4R deﬁ-
ciency is a sufﬁciently common cause of childhood obesity
(5.4% in our cohort of 3,000 children [44]; S.O. and I.S.F.,
personal observations) for MC4R gene analysis to justify
becoming a routine part of the evaluation of the severely
obese child. Heterozygous carriers of loss-of-function mu-
tations in leptin (45) and POMC (46) have a substantially
increased risk of obesity, indicating that energy balance is
sensitive to even relatively subtle disruption in these
pathways. Perhaps most interestingly, all genetic defects
causing monogenic human obesity thus far described
cause obesity principally by disrupting satiety mecha-
nisms. In the case of the MC4R, where directly observed
studies of spontaneous food intake at ad libitum meals
have been undertaken (44), there is a remarkable relation-
ship with molecular phenotype, with subjects who carry
mutations that totally abrogate signaling eating more at a
test meal than those who have mutations that only par-
tially disrupt signaling.
Thus, recently acquired information regarding the etiol-
ogy of monogenic forms of human obesity has demon-
strated that obesity can be an inherited neurobehavioral
disorder. Indeed, since MC4R deﬁciency is present in
1/1,000 U.K. Caucasians (47), this is not a particularly
rare phenomenon. However, it is clearly important to
consider the extent to which the genetic underpinnings of
common forms of obesity might affect the same processes.
Common genetic variants predisposing to obesity are
now being identiﬁed and appear to affect the same
processes. The study of the genetics of common obesity
has been dogged for many years by a profusion of studies
of candidate genes, most of which have been inadequately
powered to generate ﬁrm conclusions. The power of
genome-wide association studies undertaken in large sam-
ple sets has ﬁnally paid dividends, and in 2007, we saw the
emergence of the ﬁrst common genetic variant that un-
questionably alters human adiposity. Individuals who are
homozygous for the high-risk allele (AA) of FTO weigh on
average 3 kg more than individuals with two low-risk
alleles, with heterozygotes having an intermediate risk
(48). This has been replicated in multiple studies, and the
statistical evidence for its association with adiposity, at
least in Caucasians, is overwhelming. Gerken et al. (49)
recently demonstrated that FTO encodes a member of the
2-Oxoglutatate–dependent dioxygenase family. Impor-
tantly, its highest level of expression is in the brain and in
the arcuate nucleus of the hypothalamus, where its ex-
pression is altered by fasting and feeding (49). Although
the single-nucleotide polymorphisms that are most highly
associated with obesity are within an intron of the FTO
gene, it is still possible that this variant affects the expres-
sion of other genes in the vicinity, so it is not yet
conclusively proven that alterations in function or amount
of the FTO protein is a key determinant of body weight.
Nonetheless, from what we know so far, it seems most
likely that intronic variation in the FTO gene inﬂuences
obesity through its effects on some brain process relevant
to energy balance. Interestingly, Tschritter et al. (50) have
recently shown evidence that the human brain’s cerebro-
cortical responses to insulin (measured by magneto-
encephalogram) are inﬂuenced by the FTO genotype.
Whereas many previous candidate gene studies were of
inadequate size to come up with conclusive results, the
use of meta-analysis can distil information from a variety
of sources and come up with more reliable conclusions
regarding associations. Of the meta-analyses done to date,
those investigating a speciﬁc amino acid variant in the
MC4R receptor have provided the most convincing evi-
dence for an effect on body weight (51,52). Again, as we
know that disruption of MC4R function effects appetite
and food intake, it is highly likely that commoner variants
in the same gene will have effects that are different only in
degree.
Over the next few months, a larger number of genetic
variants will emerge as genome-wide association results
are pooled and replicated. We predict that these studies
will reveal variants in a number of other genes expressed
in the central nervous system and inﬂuencing appetite and
satiety.
How do these genetic variants interact with environ-
mental factors to explain the obesity epidemic? Only
in very recent human history has the majority of people in
developed and many developing countries had ready ac-
cess to more daily calories than are required to sustain
health and maintain adequate nutritional stores. This has
principally resulted from two factors: the reduction in the
need for strenuous physical activity in the workplace and
in the home, which has reduced the requirements for
ingested energy, and the abundance, ready availability,
palatability, and relative cheapness of food augmented by
its aggressive commercial promotion (4). The relative
importance of these factors probably varies across geo-
graphical locations and socioeconomic groups. Although
there have always been some obese people in all societies,
other than those with very limited access to food, these
factors have conspired in the very recent past to ensure
that all individuals with an intrinsic tendency to gain
weight over time can readily do so. However, it is impor-
tant to point out that, even in places where obesity is very
common, there are still many lean people (5). The very
high heritability of adiposity suggests that the reasons for
those inter-individual differences in susceptibility are
likely to have a biological rather than a moral explanation.
One consistent epidemiological ﬁnding that requires
explanation is the fact that, in highly developed countries
at least, the prevalence of obesity is inversely associated
with both socioeconomic status and educational status
(4). At ﬁrst glance, this seems to be powerful evidence that
poor and/or less educated people are either subject to
more of the environmental factors that drive obesity or are
less able to consciously counteract the same environmen-
tal obesogenic forces that are exerted across the whole
population. An implied corollary of the second interpreta-
tion is that economic poverty and/or lack of education
impairs a person’s ability to resist the current obesogenic
environment. Although these conjectures may well be
true, there is a third potential contributor to the associa-
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obesity that is much less frequently discussed. In a classic
paper, Gortmaker et al. (6) demonstrated that obese
teenagers, when matched for parental income and scho-
lastic achievement, had considerably higher rates of eco-
nomic poverty in adult life, strongly suggesting that, in
highly developed societies, obesity may be a cause of
economic disadvantage rather than simply a consequence.
These data have been replicated elsewhere and strongly
suggest that, at least in developed Westernized countries,
obesity can drive downward social and economic drift
(53). Thus, it is at least plausible that those who may be
biologically and genetically predisposed to obesity run the
risk of acquiring less social, economic, and educational
capital throughout their life.
An evolutionary perspective. For more than 40 years,
the Neel Thrifty Gene hypothesis has dominated thinking
about the evolution of susceptibility to human obesity
(54). However, there are a number of serious problems
with this hypothesis, including that, even in areas where
obesity is very common, a large number of people remain
lean. If there are strong environmentally based evolution-
ary drivers for particular traits (exempliﬁed by the case of
sunlight exposure and skin color [55]), alleles that favor
survival tend to become rapidly ﬁxed in populations.
Speakman (56–58) recently expounded what we ﬁnd to be
a more compelling coherent evolutionary scenario, incor-
porating modern knowledge of the biology of energy
balance to a satisfying degree. He hypothesizes that ran-
dom natural variation in “hypothalamic energy balance set
points” has occurred over millions of years of primate
evolution. Whereas variants that would tend to produce a
state of low energy stores would have been systematically
selected against, at least in part because of their adverse
impact of reproductive success, upward drifts in such set
points would have been allowed to persist (rather than
being positively selected for, as the “thrifty gene” hypoth-
esis would have it). This upward drift would be particu-
larly prominent because the formation of organized social
groups and the discovery of ﬁre, both of which occurred
around 2,000,000 years ago, made our ancestors less
susceptible to predation. Not particularly emphasized by
Speakman, but likely to be important, is the probability
that such natural tendencies toward an upward drift in
adipose stores may rarely have actually manifested them-
selves as obesity because of the high energy cost of
obtaining food during most of human evolution. It is only
in the past 50 years or so, when for the ﬁrst time in human
history the majority of people in the developed and
developing world can readily access sufﬁcient daily calo-
ries to exceed the calories expended in acquiring them,
that those with intrinsically higher set points have mani-
fested their “obesity potential” on a grand scale. Unlike the
“thrifty gene” hypothesis, this scenario provides a credible
explanation for the fact that even in places where obesity
is very common, a substantial proportion of the population
remains lean.
Conclusions. For medical, social, and economic reasons,
most obese people are highly motivated to lose weight but
ﬁnd it difﬁcult to lose weight and, if they succeed, even
more difﬁcult to maintain weight loss (59). The biology
that underpins those difﬁculties is at last becoming clear.
However, such information is certainly failing to ﬁlter
through to the public. Here is a respected (if avowedly
acerbic) Sunday Times journalist responding to thoughts
that the U.K. government might ﬁnancially motivate
healthy eating: “Perhaps instead of offering fat people
money, which they will only spend on pies, we should
once again stigmatise them. Schoolchildren could be en-
couraged to pelt fat classmates with cakes, exclude them
from playground activities, and subject them to cruel jibes.
And pinch them on their horrible ﬂeshy arms during
assembly. Fat adults could be forced to pay for two seats
on public transport, could be given the worst seats in
restaurants, and scolded over their choice of dessert.
‘Have the fruit salad, you fat pig,’ and so on. Most obesity
is, after all, a consequence of stupidity and indolence and
not of some genetic afﬂiction. It is a lifestyle choice which
people would be less inclined to adopt if they knew we all
hated them for it...”( Sunday Times, 27 January 2008).
There is an obvious element of “playing to the gallery” in
this tirade, but it reveals an interesting attitude that we
strongly suspect is not restricted to journalists. It is
puzzling that obesity can engender such moral revulsion
and even “hatred” when it is a condition that only afﬂicts
the sufferer. Despite this, rather than eliciting sympathy
for a serious medical condition, obesity seems often to
elicit a reaction that might be more understandable if
directed at people parking inappropriately in disabled
parking spaces or serially cheating on their spouses. The
reasons for this revulsion are complex, culture speciﬁc,
and more likely to be illuminated by philosophers and
social anthropologists than by biologists, but it is clear
that we have a long way to go before convincing the public
and even many doctors that obesity is an afﬂiction worthy
of sympathy and serious medical research.
As the fruits of current large-scale genetic approaches
continue to emerge, we predict that many, and perhaps the
majority, of genetic variants predisposing to obesity will
do so through inﬂuencing appetitive phenomena such as
satiety and the response to food cues, many of which have
been shown to be heritable. Indeed, we have known for 40
years or more that quantitative measures of such appetite-
related variables are clearly linked to obesity (60) and that
measurable and stable measures of eating behavior are
heritable (61). The notion that genes can affect our appar-
ently voluntary behavior is understandably uncomfortable
to many. It can be perceived as a challenge to the concept
of human “free will” and the notion that we are in full
conscious control of all our behaviors. However, the
history of human science from Copernicus through Dar-
win to modern neurobiology has continually challenged
the notion of human centrality to, and control over, the
processes of nature. As evidence for the biological basis
for inherited inﬂuences over certain basic human behav-
iors becomes more established and accepted, we hope
that this will lead to a more enlightened attitude toward
people with obesity and a reduction in discrimination
against them. Importantly, a better understanding of the
detailed biology of appetite should lead to improved
targeted pharmacotherapy. It is highly plausible that the
inherent appetite-related factors that promote increased
food intake and drive obesity (e.g., impaired satiety,
enhanced responsiveness to visual food-related cues, or
increased sense of hunger between meals) will vary mark-
edly between people and that pharmacological and/or
behavioral tools could be speciﬁcally targeted based on a
much greater understanding of the neurobiological basis
for these different aspects of appetitive behavior.
A commonly expressed belief of people who are natu-
rally lean is that, as they ﬁnd little difﬁculty in controlling
their weight, they are puzzled as to how people who are
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assume that this is some sort of adverse life choice born of
moral weakness. Whereas there is no doubt that emotional
stresses and other factors can predispose to overeating, it
is crucial that we recognize that the drive to eat varies
enormously between people, with a strong genetic under-
pinning for that variability. Because of this, the conscious
effort that needs to be made by the obese to slim down to
a normal body weight is likely to be far greater than that
required for a naturally lean person to remain so. This not
only refers to the issue of greater appetitive drive but also
to the neuroendocrine adaptations to weight loss that tend
to conserve energy in the “reduced obese” state, making
continued weight loss harder still (62,63).
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